PRGO Perrigo Company plc
Stock · NYSE · Ireland · Healthcare · IE00BGH1M568
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Perrigo Company plc, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:28. Information, not advice.
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 0.82 | — | — | Upcoming |
| 04 Nov 2026 06:00 | 0.53 | 0.60 | +12.4% | Beat |
| 05 Aug 2026 06:00 | 0.36 | 0.50 | +40.9% | Beat |
| 06 May 2026 06:00 | 0.31 | 0.43 | +40.2% | Beat |
| 26 Feb 2026 06:00 | 0.78 | 0.77 | -1.3% | Miss |
| 05 Nov 2025 06:00 | 0.77 | 0.80 | +3.9% | Beat |
| 06 Aug 2025 06:00 | 0.59 | 0.57 | -4.0% | Miss |
| 07 May 2025 06:00 | 0.57 | 0.60 | +6.1% | Beat |
| 27 Feb 2025 17:00 | 0.92 | 0.93 | +0.9% | In line |
| 06 Nov 2024 06:00 | 0.81 | 0.81 | -0.2% | In line |
| 02 Aug 2024 06:00 | 0.46 | 0.53 | +16.0% | Beat |
| 07 May 2024 06:00 | 0.23 | 0.29 | +24.3% | Beat |
| 27 Feb 2024 06:00 | 0.83 | 0.86 | +3.6% | Beat |
| 07 Nov 2023 06:00 | 0.63 | 0.64 | +2.4% | Beat |
| 08 Aug 2023 06:00 | 0.51 | 0.63 | +23.5% | Beat |
| 09 May 2023 06:00 | 0.43 | 0.45 | +4.7% | Beat |
| 27 Feb 2023 16:00 | 0.77 | 0.75 | -2.6% | Miss |
| 08 Nov 2022 06:00 | 0.67 | 0.56 | -16.2% | Miss |
| 09 Aug 2022 06:00 | 0.44 | 0.43 | -2.6% | Miss |
| 11 May 2022 06:00 | 0.42 | 0.33 | -21.6% | Miss |
| 01 Mar 2022 07:00 | 0.56 | 0.60 | +6.7% | Beat |
| 10 Nov 2021 06:00 | 0.65 | 0.45 | -31.1% | Miss |
| 11 Aug 2021 06:00 | 0.61 | 0.50 | -18.0% | Miss |
| 11 May 2021 06:00 | 0.57 | 0.50 | -11.6% | Miss |
| 01 Mar 2021 07:00 | 1.00 | 0.93 | -7.3% | Miss |
| 04 Nov 2020 16:00 | 0.86 | 0.93 | +8.7% | Beat |
| 05 Aug 2020 07:00 | 0.87 | 1.03 | +17.8% | Beat |
| 30 Apr 2020 06:00 | 1.04 | 1.14 | +9.8% | Beat |
| 27 Feb 2020 06:00 | 1.06 | 1.06 | -0.4% | In line |
| 06 Nov 2019 06:00 | 0.94 | 1.04 | +10.7% | Beat |
| 08 Aug 2019 06:00 | 0.80 | 0.86 | +8.0% | Beat |
| 08 May 2019 17:00 | 0.94 | 1.07 | +13.8% | Beat |
| 27 Feb 2019 16:00 | 1.00 | 0.97 | -2.9% | Miss |
| 08 Nov 2018 06:00 | 1.04 | 1.09 | +5.3% | Beat |
| 09 Aug 2018 | 1.20 | 1.22 | +1.6% | Beat |
| 08 May 2018 | 1.14 | 1.26 | +10.4% | Beat |
| 01 Mar 2018 17:00 | 1.25 | 1.28 | +2.5% | Beat |
| 09 Nov 2017 | 1.11 | 1.39 | +25.7% | Beat |
| 10 Aug 2017 02:00 | 0.92 | 1.22 | +32.3% | Beat |
| 30 May 2017 17:00 | 0.99 | 1.05 | +5.7% | Beat |
| 22 May 2017 18:00 | 1.82 | 1.24 | -31.9% | Miss |
| 10 Nov 2016 01:00 | 1.56 | 1.65 | +5.9% | Beat |
| 10 Aug 2016 06:00 | 1.98 | 1.93 | -2.7% | Miss |
| 12 May 2016 05:00 | 1.73 | 1.75 | +1.2% | Beat |
| 18 Feb 2016 06:00 | 1.93 | 1.80 | -6.8% | Miss |
| 22 Oct 2015 06:00 | 1.74 | 1.76 | +1.0% | Beat |
| 05 Aug 2015 07:00 | 1.96 | 2.18 | +11.1% | Beat |
| 06 Nov 2014 06:00 | 1.44 | 1.40 | -2.8% | Miss |
| 14 Aug 2014 07:00 | 1.55 | 1.74 | +12.0% | Beat |
| 07 May 2014 08:00 | 1.51 | 1.31 | -13.3% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 4.3B | -2.8% | -1.4B | -33.5% | -10.29 | -723.2% | 145.1M |
| 2024 | 4.4B | -6.1% | -171.8M | -3.9% | -1.25 | -1,288.9% | 244.6M |
| 2023 | 4.7B | +4.6% | -12.7M | -0.3% | -0.09 | +91.3% | 303.8M |
| 2022 | 4.5B | — | -140.6M | -3.2% | -1.04 | — | 210.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 20 Dec 2021 | 37.45 | 38.72 | 36.56 | 38.43 | +1.88% | 3,028,200 | |
| 17 Dec 2021 | 37.07 | 37.89 | 36.62 | 37.72 | +2.03% | 3,092,000 | |
| 16 Dec 2021 | 36.46 | 37.13 | 36.22 | 36.97 | +1.68% | 1,509,200 | |
| 15 Dec 2021 | 36.19 | 36.45 | 35.37 | 36.36 | +0.36% | 1,322,600 | |
| 14 Dec 2021 | 35.90 | 36.57 | 35.89 | 36.23 | +0.28% | 1,212,300 | |
| 13 Dec 2021 | 36.26 | 36.41 | 35.89 | 36.13 | -1.09% | 1,332,800 | |
| 10 Dec 2021 | 36.85 | 37.12 | 36.11 | 36.53 | -0.33% | 1,272,800 | |
| 09 Dec 2021 | 37.16 | 37.37 | 36.57 | 36.65 | -2.32% | 1,092,300 | |
| 08 Dec 2021 | 37.63 | 37.80 | 37.08 | 37.52 | +0.29% | 869,700 | |
| 07 Dec 2021 | 37.35 | 37.85 | 37.13 | 37.41 | +1.00% | 1,292,700 | |
| 06 Dec 2021 | 36.18 | 38.04 | 36.04 | 37.04 | +3.49% | 1,748,100 | |
| 03 Dec 2021 | 36.18 | 36.45 | 35.53 | 35.79 | -0.11% | 1,269,800 | |
| 02 Dec 2021 | 35.67 | 36.29 | 35.34 | 35.83 | -0.06% | 2,494,500 | 0.2400 |
| 01 Dec 2021 | 37.00 | 37.02 | 35.77 | 35.85 | -2.34% | 2,662,500 | |
| 30 Nov 2021 | 37.14 | 37.25 | 36.52 | 36.71 | -2.05% | 1,972,700 | |
| 29 Nov 2021 | 37.78 | 37.91 | 36.76 | 37.48 | -0.79% | 1,309,400 | |
| 26 Nov 2021 | 38.13 | 38.56 | 37.44 | 37.78 | -2.70% | 676,200 | |
| 24 Nov 2021 | 39.13 | 39.29 | 38.67 | 38.83 | -0.94% | 1,068,600 | |
| 23 Nov 2021 | 39.19 | 39.84 | 38.95 | 39.20 | -0.13% | 1,685,100 | |
| 22 Nov 2021 | 40.22 | 40.55 | 38.71 | 39.25 | -4.59% | 3,131,900 | |
| 19 Nov 2021 | 41.70 | 41.73 | 40.95 | 41.14 | -1.15% | 1,273,600 | |
| 18 Nov 2021 | 42.88 | 42.92 | 41.45 | 41.62 | -2.62% | 1,074,900 | |
| 17 Nov 2021 | 43.13 | 43.46 | 42.54 | 42.74 | -0.58% | 1,240,300 | |
| 16 Nov 2021 | 42.77 | 43.17 | 42.48 | 42.99 | +0.54% | 1,234,800 | |
| 15 Nov 2021 | 43.46 | 43.57 | 42.61 | 42.76 | -1.25% | 1,044,300 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Perrigo Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 08 Nov 2026 05:14
- Perrigo (PRGO) Stock Could Trade Below Fair Value Following A 54% Five Year Fall (opens in a new tab) Simply Wall St. · 07 Nov 2026 15:19
- How Investors May Respond To Perrigo (PRGO) Weak 2026 Outlook (opens in a new tab) Simply Wall St. · 07 Nov 2026 12:16
- Is Perrigo (PRGO) Undervalued After Its 2026 Sales Guidance Cut? (opens in a new tab) Simply Wall St. · 07 Nov 2026 05:17
- Perrigo: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 07 Nov 2026 02:31
- Perrigo Co PLC (PRGO) (Q3 2026) Earnings Call Highlights: Margin Gains and Share Growth Offset ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 01:10
- Perrigo (PRGO) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 19:01
- Perrigo Company plc Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 04 Nov 2026 18:53
- Perrigo Company plc (PRGO) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 17:44
- Perrigo Company plc Reports Third Quarter 2026 Results and Agreement to Divest Infant Formula Business for Up to $175 Million (opens in a new tab) Fintel · 04 Nov 2026 14:21
- Perrigo (PRGO) Reports Q3 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 04 Nov 2026 13:30
- Perrigo Company plc 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 04 Nov 2026 13:02
- Perrigo (NYSE:PRGO) Q3 2026 Earnings: EPS Beat Offsets Slight Revenue Miss (opens in a new tab) ChartMill · 04 Nov 2026 12:37
- Perrigo (PRGO) Surpasses Q3 Earnings Estimates (opens in a new tab) Zacks · 04 Nov 2026 11:50
- Perrigo: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 11:40
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 15.71 USD
- Market cap
- 2.2B
- Dividend yield
- 7.32%
- 5-year average yield
- 3.79%
- Payout ratio
- 1,349%
- Last dividend
- 0.2900 USD · 27 Nov 2026
- Next ex-dividend date
- 27 Nov 2026
- Exchange
- NYSE
- Country
- Ireland
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 28 Aug 2026 | 0.2900 USD |
| 29 May 2026 | 0.2900 USD |
| 02 Mar 2026 | 0.2900 USD |
| 29 Aug 2025 | 0.2900 USD |
| 30 May 2025 | 0.2900 USD |
| 07 Mar 2025 | 0.2900 USD |
| 29 Nov 2024 | 0.2760 USD |
| 30 Aug 2024 | 0.2760 USD |
| 31 May 2024 | 0.2760 USD |
| 07 Mar 2024 | 0.2760 USD |
| 30 Nov 2023 | 0.2730 USD |
| 31 Aug 2023 | 0.2730 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 25.0 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 1.8 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 7.3 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 10.0 / 10 | — |
| Analysts How far the analysts' average target is from today's price. | 3.9 / 5 |
|
- Score capped at 50: the dividend was cut recently
- The dividend is above the earnings (payout 1349%)
- Heavy debt: net debt is 5.4× EBITDA
- Thin interest cover: operating profit is only 1.9× the interest
- The dividend paid in the last 12 months is lower than in the 12 before
- The last full year was a loss
- Revenue has fallen two years in a row
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 18 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 6.9× | Good | 14.89× |
| Price / book | 0.9× | Good | 3.81× |
| Price / sales | 0.54× | Good | 3.19× |
| EV / EBITDA | 9.34× | Good | 12.63× |
| Free cash flow yield | 32.9% | Good | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 32.6% | Fair | 58.6% |
| Operating margin | 3% | Weak | 7.8% |
| Net margin | -43.3% | Weak | 2.8% |
| Return on equity | -50.2% | Weak | 5.7% |
| Return on assets | 1.6% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -1.5% | Weak | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.42× | Fair | 0.48× |
| Net debt / EBITDA | 5.41× | Weak | 1.6× |
| Interest cover | 1.92× | Weak | 2.69× |
| Current ratio | 2.35× | Good | 2.39× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 1,348.8% | Weak | 0% |
| Payout of free cash flow | 22% | Good | 28.8% |
| Payout of free cash flow (3 years) | 66.5% | Fair | — |
| Dividend growth / year | 7.7% | Good | 7.1% |
| Years of rising dividends | 0 | Weak | 2 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow PRGO and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.